Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy
Transkatheterale linksventrikuläre Rekonstruktion bei ischämischer Herzinsuffizienz und dilatativer Kardiomyopathie
Catheterization and Cardiovascular Interventions · 2026-03 · 107 (4) · 898-908
DOI: 10.1002/ccd.70425 ↗Auf einen Blick
Eine Metaanalyse zeigte nach transkatheteraler linksventrikulärer Rekonstruktion Verbesserungen von LV-Volumen, LVEF und NYHA-Klasse. KCCQ verbesserte sich insgesamt nicht signifikant.
Fragestellung
Welche Effekte hat TLVR bei Erwachsenen mit ischämischer Herzinsuffizienz oder dilatativer Kardiomyopathie?
Methode
Metaanalyse nach PRISMA 2020; Suche in PubMed, Embase, Scopus und Cochrane Library bis Juli 2025; eingeschlossen wurden single-arm Interventions- und Beobachtungsstudien.
Ergebnisse
17 Studien. TLVR senkte das LVEDV (MD −25,94 mL; p < 0,00001), erhöhte die LVEF (+6,69 %; p < 0,00001) und verbesserte die NYHA-Klasse (MD −0,73; p = 0,02). KCCQ insgesamt nicht signifikant.
Einschränkungen
Hohe Heterogenität, kleine Kohorten und kurze Nachbeobachtung.
Schlussfolgerung der Autor:innen
Die Autor:innen berichten konsistente Verbesserungen von Remodeling, Funktion und Symptomen, sehen aber Bedarf an großen randomisierten Studien zur Dauerhaftigkeit, zum Überlebensnutzen und zur Patient:innenselektion.
Kernaussagen
- LVEDV sank um MD −25,94 mL
- LVEF stieg um +6,69 %
- KCCQ insgesamt nicht signifikant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Metaanalyse in Catheterization and Cardiovascular Interventions, published online on 2025-12-15. Written by Muhammad Mohid Haroon and 19 co-authors. Institution: Ameer-ud-Din Medical College/Lahore General Hospital, Lahore, Pakistan. Major MEDLINE topics: Cardiomyopathy, Dilated, Heart Failure, Ventricular Function, Left, Cardiac Catheterization. 9 references. The full text is freely available (open access, CC BY 4.0).
Topics: Herzinsuffizienz
Abstract (original language)
Ischemic heart disease is the leading global cause of death and frequently progresses to ischemic heart failure (IHF) after myocardial infarction through adverse left ventricular (LV)remodeling. Surgical LV restoration improves ventricular geometry and function but is limited by invasiveness and inconsistent outcomes. Transcatheter Left Ventricular Restoration (TLVR) has emerged as a minimally invasive alternative,employing devices such as Revivent TC, AccuCinch, and Parachute to reduce LV volume, wall stress, and improve LV ejection fraction (LVEF). While several studies have reported promising results, no prior meta‐analysis has synthesized the evidence across devices. This meta‐analysis followed PRISMA 2020 guidelines. PubMed, Embase, Scopus, and Cochrane Library were searched through July 2025. Eligible studies included adult patients with IHF or dilated cardiomyopathy undergoing TLVR and reporting outcomes including LVEF, LV end‐diastolic volume (LVEDV), New York Heart Association (NYHA) class, or Kansas City Cardiomyopathy Questionnaire (KCCQ). Single‐arm interventional and observational cohort studies were included. Data extraction was performed by four reviewers, with bias assessed using ROBINS‐I and the Newcastle–Ottawa Scale. Pooled mean differences (MD) were calculated using a random‐effects model (Hartung–Knapp–Sidik–Jonkman). Seventeen studies were included, with baseline LVEF 22.8%–38% and LVEDV 75–235 mL. TLVR significantly reduced LVEDV (MD −25.94 mL; p < 0.00001), increased LVEF (+6.69%; p < 0.00001), and improved the NYHA class (MD −0.73; p = 0.02). KCCQ scores improved in some studies but were not significant overall. Revivent TC and AccuCinch showed consistent benefits, whereas Parachute outcomes were more variable. This meta‐analysis of TLVR demonstrates consistent improvements in LV remodeling, function, and symptoms. Nonetheless, high heterogeneity, small cohorts, and limited follow‐up highlight the need for large randomized trials to establish durability, survival benefit, and refine patient selection.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Ameer-ud-Din Medical College/Lahore General Hospital, Lahore, Pakistan.
- Department of Medicine, Jersey Shore University Medical Centre, Hackensack Meridian Health, Neptune, New Jersey, USA.
- Peoples University of Medical and Health Sciences, Nawabshah, Pakistan.
- Department of Medicine, Ziauddin Medical College, Karachi, Pakistan.
- Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- King Edward Medical University, Lahore, Pakistan.
ORCID profiles: Saqlain Haider, Muhammad Umer, Muhammad Muneeb Murtaza
Cite
APA
Haroon, M. M., Ahmad, F., Ali, R., Haider, S., Masood, A. Z., Yaseen, U., Rehman, T. A. Z. U., Sardar, M. A., Umer, M., Aswathappa, S., Sabri, M. S., Murtaza, M. M., Ali, R., Kumar, S., Ali, S., Gohar, N., Bakr, M., Patel, S., Hussain, M. A., & Alenezi, F. (2026). Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy. Catheterization and Cardiovascular Interventions, 107(4), 898-908. https://doi.org/10.1002/ccd.70425
Vancouver
Haroon MM, Ahmad F, Ali R, Haider S, Masood AZ, Yaseen U, et al. Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy. Catheterization and Cardiovascular Interventions. 2026;107(4):898-908. doi:10.1002/ccd.70425
BibTeX
@article{Haroon2026,
author = {Haroon, Muhammad Mohid and Ahmad, Faizan and Ali, Ramsha and Haider, Saqlain and Masood, Areehah Zafar and Yaseen, Usama and Rehman, Taha Ahmad Zaka Ur and Sardar, Muhammad Abdullah and Umer, Muhammad and Aswathappa, Shruthi and Sabri, Muhammad Salman and Murtaza, Muhammad Muneeb and Ali, Rubiya and Kumar, Sunny and Ali, Sameer and Gohar, Najam and Bakr, Mohamed and Patel, Swapnil and Hussain, Mohammad A and Alenezi, Fawaz},
title = {Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {4},
pages = {898--908},
doi = {10.1002/ccd.70425}
}
EUVIMED